FDA, Mounjaro and Zepbound

FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for these medications.
Zepbound, Mounjaro shortages are resolved, FDA confirms
The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a limited grace period before taking any enforcement actions.
FDA keeps Mounjaro off shortage list after reevaluation
The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a reevaluation of its decision to remove it from federal drug shortage list
FDA Says Shortage of Eli Lilly’s Zepbound Is Over, but Gives Compounders a Grace Period
The Food and Drug Administration said Thursday that the longstanding shortage of Eli Lilly’s weight-loss drug Zepbound and its Type 2 diabetes medicine Mounjaro is officially over. The determination comes two months after the FDA first removed the ingredient in both medicines,
The FDA says the Zepbound shortage is over. That's rattling the weight loss industry
The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide—the active ingredient in Eli Lilly’s (LLY) popular diabetes and weight-loss drugs Mounjaro and Zepbound—is officially over.
FDA reaffirms end of Mounjaro shortage
FDA resolves two-year shortage of Mounjaro and Zepbound after pushback from compounding pharmacies. Lawsuit filed, but agency reaffirms decision.
A millionaire tech 'biohacker' is microdosing Zepbound in pursuit of youth
Bryan Johnson, the tech entrepreneur and millionaire who became famous for infusing his son’s plasma into his blood in an ...
Zepbound users discuss weight loss after preliminary research touts effectiveness
A preliminary study on popular weight loss drugs finds participants shed more weight on Zepbound than on Novo Nordisk’s ...
verywellhealth on MSN5d
Zepbound Helps People Lose More Weight Than Wegovy, According to Eli Lilly Trial
Over 18 months, people taking Zepbound lost more weight on average than those on Wegovy, according to the first head-to-head ...
Yahoo Finance13d
How to Play LLY Stock as Zepbound Beats NVO's Wegovy in Obesity Study
Lilly markets tirzepatide as Zepbound for obesity and as Mounjaro for type II diabetes. Though demand for the two drugs remains massive, Mounjaro and Zepbound’s sales were hurt due to ...
Healthline4d
Where to Buy Mounjaro Online Safely in 2025: Advice from Our Experts
The program includes a 30-minute video chat with a licensed and board certified doctor who can write you a prescription for Mounjaro if appropriate. Ro offers Zepbound, which contains the same ...
FDA: Knockoff versions of Lilly obesity drug must come off the market
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes ...